Justice Department issues subpoenas to clinics and drugmakers over gender-affirming care
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
The Department of Justice has issued \u201cnearly 20 subpoenas\u201d to clinics that provide gender-affirming care in relation to \u201ctransition-related investigations,\u201d DOJ chief of staff Chad Mizelle said at an event held by the Federal Trade Commission Wednesday. The department has also issued subpoenas to major manufacturers of \u201cthe drugs used in trans-related medical interventions\u201d in relation to investigations around drug marketing laws and the Food, Drug, and Cosmetic Act, Mizelle added.<\/p>\n
The announcement is the latest Trump administration move to target providers of gender-affirming care. In June, the FBI requested tips<\/a> from the public on clinics that provide this care, and in May, the Centers for Medicare and Medicaid Services sent letters<\/a> to nine hospitals requesting information about their protocols. The actions follow the executive order<\/a> President Trump issued one week into his presidency that directed the withholding of federal funds from any hospital that provides gender-affirming care to people under age 19.\u00a0<\/p>\n